During the corresponding time, Ge Healthcare Technologies Inc recorded a revenue increase by 7.17 % year on year, sequentially revenue fell by -11.43 %. While revenue at the Ge Healthcare Technologies Inc 's corporate clients
Ge Healthcare Technologies Inc's Comment on Sales, Marketing and Customers
The company operates in over 160 countries, serving hospitals, health systems, and researchers from public, private, academic, and government institutions. Its solutions focus on healthcare challenges to enhance care delivery, reduce disease burden, and improve patient outcomes. The business is divided into four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
The Imaging segment supports clinical specialties including oncology, cardiology, neurology, nuclear medicine, orthopedics, women’s health, pediatrics, and surgery. Its product lines encompass Molecular Imaging (MI), Computed Tomography (CT), Magnetic Resonance (MR), Women’s Health, and X-ray. Molecular Imaging products facilitate visualization at cellular and subcellular levels and include cyclotrons, PET, PET/CT, SPECT, PET/MR, and nuclear medicine technologies. Computed Tomography provides three-dimensional anatomical images for detecting tumors, lesions, blocked blood vessels, heart conditions, fractures, and trauma injuries. Magnetic Resonance delivers detailed anatomical and functional imaging for disease detection, diagnosis, and treatment monitoring of conditions such as stroke, cancer, trauma, aneurysm, and multiple sclerosis.
The company’s customers and markets include GE Aerospace and General Electric Company.
News about Ge Healthcare Technologies Inc Contracts
In a compelling announcement at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, GE HealthCare (Nasdaq: GEHC) unveiled its plans to expand its radiation oncology portfolio and introduce innovative AI-enabled technologies. The spotlight was on the new MR Contour DL, highlighting GE HealthCare s commitment to revolutionizing cancer treatment and optimizing diagnostic processes for clinicians.The company showcased its upgraded Intelligent Radiation Therapy (iRT) platform, which aims to standardize complex workflows, potentially shortening the timeline from diagnosis to treatment. These advancements are particularly crucial as healthcare systems worldwide are increasin...
Revolutionary Medical Advancements: GE HealthCare s Latest CT Innovation Amidst Financial HurdlesIn a significant leap forward for medical imaging technology, GE HealthCare has unveiled its state-of-the-art Revolution Vibe CT system, featuring the groundbreaking Unlimited One-Beat Cardiac imaging. This announcement was made at the esteemed American College of Cardiology 2025 meeting in Chicago, highlighting the company s commitment to advancing healthcare technology even amidst financial fluctuations.The Revolution Vibe CT system is poised to transform cardiac imaging by delivering consistent, high-quality images, regardless of challenging conditions such as atrial fibrillation or heavily calcified coronari...
In a significant advancement for cardiac imaging, GE HealthCare has unveiled its latest innovation the Revolution Vibe computed tomography (CT) system at the American College of Cardiology 2025 meeting in Chicago. This groundbreaking technology introduces a robust suite of features, including Unlimited One-Beat Cardiac imaging, that promises to redefine the landscape of cardiovascular diagnostics.As healthcare continues to evolve, the need for high-quality, easily accessible imaging capabilities has never been more crucial. The Revolution Vibe CT system is expertly designed to meet these demands, offering consistent and accurate imaging even in challenging clinical situations such as atrial fibrillation ...
In a remarkable move to reshape cardiology, GE HealthCare has announced pivotal innovations aimed at transforming the care pathway for cardiovascular patients in the U.S. market. This announcement comes in conjunction with the American College of Cardiology s (ACC) annual conference, where the spotlight is on advancements in cardiac care. As the company s innovations promise to enhance diagnosis and treatment, GE HealthCare s stock performance tells a different story, raising questions about its market positioning amidst challenging economic conditions.During this transformative period, GE HealthCare s Technologies Inc. shares have struggled, trailing behind the overall market performance. Over the past year...
In an era where innovation in healthcare technology is paramount, GE HealthCare (Nasdaq: GEHC) has taken a significant leap forward by unveiling its Genesis Portfolio, a suite of cloud enterprise imaging software-as-a-service (SaaS) solutions designed for healthcare organizations. Announced at the Radiological Society of North America (RSNA) annual meeting held in Las Vegas, this new offering aims to enhance the efficiency and precision of healthcare delivery while providing streamlined workflows and optimizing the utilization of both capital and IT resources. The Genesis Portfolio: Revolutionizing Healthcare OperationsThe Genesis Portfolio comprises four key features that will be commercially released short...
In a significant advancement for post-surgical patient care, GE HealthCare (Nasdaq: GEHC) has released findings from a two-phase pilot study conducted in partnership with Cleveland Clinic. The study, published in the peer-reviewed Journal of Clinical Anesthesia, underscores the effectiveness of the Portrait Mobile continuous monitoring solution in enhancing clinical intervention while mitigating the prevalent issue of alarm fatigue among healthcare professionals.The Portrait Mobile monitoring solution, which is wireless and wearable, is designed to track vital signs in patients recovering in post-surgical wards. Alarm fatigue, a growing concern in healthcare, is characterized by an overwhelming number of ale...
Harnessing the Power of Artificial Intelligence: GE HealthCare and RadNet s Strategic Partnership in Medical Imaging In a world where the boundaries of technology continually evolve, GE HealthCare and RadNet have joined forces in a dynamic collaboration aimed at revolutionising the medical imaging landscape. This strategic venture was recently unveiled in Chicago, signifying a significant stride towards the integration of AI-powered solutions in health informatics. By melding their respective strengths, GE HealthCare and RadNet s subsidiary, DeepHealth, Inc. aspire to transform the industry’s approach to imaging systems, ultimately enhancing patient care on a global scale.At the heart of this collaboration...
In the ever-evolving landscape of medical technology, GE HealthCare is once again pushing boundaries with the introduction of the Versana Premier multi-purpose ultrasound system. This latest addition to the Versana family is characterized by features that prioritize ease-of-use, affordability, and versatility, aligning with the growing demand for innovative solutions in healthcare. User-Centric Design and Automation One of the standout attributes of the Versana Premier is its focus on user experience. In a sector that often grapples with complex and unwieldy technologies, GE HealthCare has designed this ultrasound system with the clinician in mind. According to the company, the system enables an effortless u...
In a significant move poised to reshape the landscape of medical imaging technology, GE HealthCare (Nasdaq: GEHC) has announced an agreement to acquire Intelligent Ultrasound Group PLC’s clinical artificial intelligence (AI) software business for approximately $51 million. Intelligent Ultrasound, a UK-based company renowned for its pioneering AI-driven image analysis tools, is set to bring its cutting-edge technology under the GE HealthCare umbrella. This acquisition represents a strategic expansion for GE HealthCare, which plans to integrate Intelligent Ultrasound’s AI solutions across its ultrasound portfolio. The goal is clear: to make ultrasound imaging smarter, more efficient, and user-friendly by l...
:In recent announcements, GE HealthCare and Tampa General Hospital (TGH) have further solidified their long-term partnership by outlini...
Ge Healthcare Technologies Inc’s Comment on Sales, Marketing and Customers
The company operates in over 160 countries, serving hospitals, health systems, and researchers from public, private, academic, and government institutions. Its solutions focus on healthcare challenges to enhance care delivery, reduce disease burden, and improve patient outcomes. The business is divided into four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
The Imaging segment supports clinical specialties including oncology, cardiology, neurology, nuclear medicine, orthopedics, women’s health, pediatrics, and surgery. Its product lines encompass Molecular Imaging (MI), Computed Tomography (CT), Magnetic Resonance (MR), Women’s Health, and X-ray. Molecular Imaging products facilitate visualization at cellular and subcellular levels and include cyclotrons, PET, PET/CT, SPECT, PET/MR, and nuclear medicine technologies. Computed Tomography provides three-dimensional anatomical images for detecting tumors, lesions, blocked blood vessels, heart conditions, fractures, and trauma injuries. Magnetic Resonance delivers detailed anatomical and functional imaging for disease detection, diagnosis, and treatment monitoring of conditions such as stroke, cancer, trauma, aneurysm, and multiple sclerosis.
The company’s customers and markets include GE Aerospace and General Electric Company.
Sources:
Ge Healthcare Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Ge Healthcare Technologies Inc’s corporate clients.
For your research, we’ve provided 9 tables on Ge Healthcare Technologies Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
120.66 %